July 17, 2001–ROFIN-SINAR Technologies, Inc. (Plymouth, MI/Hamburg, Germany) a developer and manufacturer of high-performance laser beam sources and laser-based solutions, announced that it intends to sell the medical laser business of Carl Baasel Lasertechnik GmbH, Starnberg, a majority-owned subsidiary of Rofin-Sinar Laser GmbH (Hamburg, Germany), to WaveLight Laser Technologie AG, (Erlangen, Germany).
Under the terms of this agreement WaveLight Laser Technologie AG will acquire Carl Baasel Lasertechnik's medical laser business, which deals with the development, manufacturing, and distribution of laser systems for aesthetic surgical applications. The integration of the medical laser business into WaveLight's corporate structure is expected to occur by the end of the year.
Since last year's acquisition of the Baasel Lasertech Group, Rofin has streamlined its business areas and focuses now on three core business units: macro, micro, and marking. As there is little overlap between the core business areas and aesthetic surgical applications and the markets for laser medicine, the company decided to sell this business segment.
“Rofin and WaveLight took a strategically important step together,” said Carl F. Baasel, founder and managing director of Carl Baasel Lasertechnik GmbH. “Due to the excellent possibilities of integration into WaveLight's business activities, the medical laser business will experience faster growth, and our company will be able to concentrate more on laser micro and marking products and system solutions for industrial applications.”